Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States

被引：0

作者：

Farber, Harrison W. ^{[1
]}

Germack, Hayley D. ^{[2
]}

Croteau, Nicole S. ^{[3
]}

Simeone, Jason C. ^{[3
]}

Tang, Fei ^{[3
]}

Paoli, Carly J. ^{[2
]}

Doad, Gurinderpal ^{[4
]}

Panjabi, Sumeet ^{[2
]}

De Marco, Teresa ^{[5
]}

机构：

[1] Tufts Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02111 USA

[2] Janssen Sci Affairs LLC, Titusville, NJ USA

[3] Cytel, Real World Evidence, Waltham, MA USA

[4] Actelion Pharmaceut, Titusville, NJ USA

[5] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA

来源：

PULMONARY CIRCULATION | 2024年 / 14卷 / 02期

关键词：

pulmonary arterial hypertension; risk factors; treatment;

D O I：

10.1002/pul2.12326

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Information on factors leading to pulmonary arterial hypertension (PAH) treatment discontinuation is limited. This study analyzed 12,902 new PAH medication users to identify predictors of treatment discontinuation. Treatment by accredited pulmonary hypertension centers and combination therapy with PAH agents from different classes were less likely to result in discontinuation.

引用

页数：5

共 50 条

[1] Economic Burden Associated with Pulmonary Arterial Hypertension in the United States
Watzker, Anna
Alsumali, Adnan
Ferro, Christine
Dieguez, Gabriela
Park, Clare
Lautsch, Dominik
El-Kersh, Karim
PHARMACOECONOMICS, 2025, 43 (01) : 83 - 91
[2] Treatment Discontinuation or Interruption in Pulmonary Arterial Hypertension
Narechania, Shraddha
Torbic, Heather
Tonelli, Adriano R.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (02) : 131 - 141
[3] Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States
Kirson, Noam Y.
Birnbaum, Howard G.
Ivanova, Jasmina I.
Waldman, Tracy
Joish, Vijay
Williamson, Todd
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (09) : 1763 - 1768
[4] Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry
Fling, Connor
De Marco, Teresa
Kime, Noah A.
Lammi, Matthew R.
Oppegard, Laura J.
Ryan, John J.
Ventetuolo, Corey E.
White, R. James
Zamanian, Roham T.
Leary, Peter J.
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (12) : 1718 - 1725
[5] ESTIMATION OF PULMONARY ARTERIAL HYPERTENSION ON PRODUCTIVITY LOSSES IN THE UNITED STATES
Joish, V. N.
Kreilick, C.
Germino, R.
Muccino, D.
VALUE IN HEALTH, 2014, 17 (03) : A118 - A118
[6] Data on clinical and economic burden associated with pulmonary arterial hypertension related hospitalizations in the United States
Chaturvedi, Abhishek
Kanwar, Manreet
Chandrika, Parul
Thenappan, Thenappan
Raina, Amresh
Benza, Raymond L.
DATA IN BRIEF, 2020, 32
[7] Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States
Burger, Charles D.
Ozbay, A. Burak
Lazarus, Howard M.
Riehle, Ellen
Montejano, Leslie B.
Lenhart, Gregory
White, R. James
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (08): : 834 - 842
[8] Treatment Patterns After Initial Therapy Among Pulmonary Arterial Hypertension Patients In The United States
Burger, C. D.
Ozbay, B.
Riehle, E.
Lenhart, G.
White, R. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[9] Economic Burden Associated with Pulmonary Arterial Hypertension in the United StatesEconomic Burden Associated With Pulmonary Arterial Hypertension in the United StatesA. Watzker et al.
Anna Watzker
Adnan Alsumali
Christine Ferro
Gabriela Dieguez
Clare Park
Dominik Lautsch
Karim El-Kersh
PharmacoEconomics, 2025, 43 (1) : 83 - 91
[10] Regional Heterogeneity in Prostanoid Utilization for Pulmonary Arterial Hypertension in the United States
Frantz, R. P.
Barst, R. J.
Turner, M.
Wason, P.
McGoon, M. D.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179

← 1 2 3 4 5 →